Skip to content

Dr. Maarten Van Marcke

Active
Private limited companyfounded 2023active for 2 yearsHam 168, 9000 Gent, BelgiumKBO/BCE: BE 1003.643.360
Summary

Dr. Maarten Van Marcke has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €257,987 and a net result of €143,771. Its solvency ranks better than 61% of 3,032 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 20-12-2023 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.361.389.576 9280 Lebbeke, since 20-12-2023
Financial year end
31 December
Peppol
Reachable since 21-12-2025

Board and ownership

Board

Financial position

97 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€189,380
▼ 2.7%
Turnover
≈ €350,000
estimated
Profit
€143,771
▼ 10.3%
Equity
€257,987
▲ 58.5%
Total assets
€366,118
▲ 81.8%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 4.38, cash €288,654Size: total assets €366,118Equity €257,987 (70.5% of total assets)Show the evidence

Checked score

Score 2025
97 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 76% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 95-5
equity 70.5% of total assets
Liquidity 95+1
short-term debt 18.7% · cash 78.8%
Profitability 100=
return on assets 39.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 01-2025: 0.3% 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.4%▲ +0.1 percentage points vs 05-2025highest value 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 4.38 (5.22 in 2024), above the usual 1.5. Short-term debt is 18.7% and cash 78.8% of total assets. 29.5% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 58% of them on solvency, 82% on liquidity, 80% on profitability and 82% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 4.38, cash €288,654
NBB · annual accounts
lowers risk · Size: total assets €366,118
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €257,987 (70.5% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2023, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
18 days early
2024
22 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 2 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €162,766 to €257,987 ▲ 58.5% View

Recent changes

  1. · Gazette deed IncorporationStarting capital €2,500 · Appointment: VAN MARCKE Maarten (director)
All 4 events

Comparable companies

These companies have the same main activity as Dr. Maarten Van Marcke: general medical practice (NACE 86210). They are comparable in size and age: total assets between €330,000 and €424,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
Dr. Maarten Van Marcke Gent€366,118€189,380
Karkide Tugba Huisarts Genk€360,960€182,084
ARTSENPRAKTIJK VANHAELEWIJN Wevelgem€365,256€195,471
Dr. Silke Viaene Hooglede€352,153€179,817
VanMedix Zoersel€339,438€184,211
Médecine Générale JPX Merbes-le-Château€329,943€186,597
Docteur Adriana CONSTANTIN Anderlecht€424,435€188,143
Full comparison

Key facts about Dr. Maarten Van Marcke

What is the company number of Dr. Maarten Van Marcke?
The company number of Dr. Maarten Van Marcke is 1003.643.360. The VAT number is the same number with BE in front: BE 1003.643.360.
Where is Dr. Maarten Van Marcke based?
The registered office is at Ham 168, 9000 Gent.Company details
What does Dr. Maarten Van Marcke do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Maarten Van Marcke?
The legal form of Dr. Maarten Van Marcke is Private limited company (BV).
When was Dr. Maarten Van Marcke founded?
Dr. Maarten Van Marcke was founded on 20-12-2023.
Is Dr. Maarten Van Marcke still active?
Yes, Dr. Maarten Van Marcke is an active enterprise in the KBO register.
What is the turnover of Dr. Maarten Van Marcke?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €189,380 and 30 comparable companies (NACE 86210). It probably lies between €270,000 and €430,000.Financials
Is Dr. Maarten Van Marcke profitable?
In financial year 2025, Dr. Maarten Van Marcke made a profit of €143,771.
Where can I find the annual accounts of Dr. Maarten Van Marcke?
Dr. Maarten Van Marcke filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Maarten Van Marcke due?
Dr. Maarten Van Marcke must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.